California has finally done it. For the first time in six years, the “glory hole” has been activated, CBS News reports. Please, people. There’s no innuendo here. We’re, of course, referring to the iconic and distinctly designed spillway in the North Bay’s Lake Berryessa, a reservoir next to the Monticello Dam. “It’s called a glory… Continue reading California Activates Gigantic Glory Hole
Tag: People
Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
SOUL study showed Rybelsus® (semaglutide) tablets 14 mg reduced the risk of major adverse cardiovascular events (MACE) by 14% (ARR 2% absolute risk reduction at 3 years) vs placebo in adults with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD)1 Oral semaglutide 14 mg demonstrated this reduction of risk on… Continue reading Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
Magna Posts 2024 Annual Report
AURORA, Ontario, March 28, 2025 (GLOBE NEWSWIRE) — Magna International Inc. (TSX: MG; NYSE: MGA) today announced that its 2024 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, Annual Information Form (AIF) and Form 40-F, are now available on the company’s website, www.magna.com. Magna has also filed these documents with the… Continue reading Magna Posts 2024 Annual Report
Why Zagato and Touring see a bright future for coachbuilding
Zagato insists that his firm will embrace new technology, rather than fear it. He cites artificial intelligence and 3D stamping as beneficial for its small-scale projects, explaining: “You don’t have to invest thousands of euros in moulds or tooling, because you can quickly build the parts to create one-off and few-off cars. We’re already building… Continue reading Why Zagato and Touring see a bright future for coachbuilding
Magna Posts 2024 Annual Report
Magna International Inc. AURORA, Ontario, March 28, 2025 (GLOBE NEWSWIRE) — Magna International Inc. (TSX: MG; NYSE: MGA) today announced that its 2024 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, Annual Information Form (AIF) and Form 40-F, are now available on the company’s website, www.magna.com. Magna has also filed these… Continue reading Magna Posts 2024 Annual Report
Nissan Plans To Introduce a Compact MPV In 2025
Nissan has just dropped the first official teaser of its upcoming compact MPV which is due for launch in India this year. The Japanese carmaker first announced plans for this MPV in December 2023, and the teaser suggests that the three-row Nissan MPV will look substantially different from the Renault Triber with which it shares… Continue reading Nissan Plans To Introduce a Compact MPV In 2025
“EV Shift Is Happening in Tamil Nadu:” Arun Murugappan
“We’re not just witnessing the EV transition — we’re building it here in Tamil Nadu,” said Arun Murugappan, Chairman of the Murugappa Group, speaking at the Autocar Professional Future Powertrain Conclave, held in partnership with Guidance Tamil Nadu. His remark captures the sentiment driving one of India’s most ambitious clean mobility transformations — led not… Continue reading “EV Shift Is Happening in Tamil Nadu:” Arun Murugappan
Should You Buy Nio While It’s Below $6?
Nio (NIO -6.03%) is a fast-growing company looking to capitalize on China’s growing electric vehicle (EV) market. It has carved out a niche in the industry with its battery swap business. However, the journey hasn’t been without its challenges. Pricing wars have put pressure on margins, and the ongoing trade tensions in the U.S. and… Continue reading Should You Buy Nio While It’s Below $6?
Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025
Semaglutide 1 mg demonstrated statistically significant and superior improvement in maximum walking distance by 13% over placebo in adults with type 2 diabetes and symptomatic PAD1 Based on STRIDE trial data, presented at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo while simultaneously published today in The Lancet, Novo Nordisk submitted a… Continue reading Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025
Rheinmetall CEO visits VW plant as defence companies look to expand
No concrete decisions were made regarding the future of the site, the spokesperson added. Rheinmetall CEO Armin Papperger visited Volkswagen‘s Osnabrueck plant on Friday as part of a delegation of Europe’s top ammunition maker, labour representatives said, in the latest sign of closer cooperation between the defence and auto sectors. Papperger earlier this month said… Continue reading Rheinmetall CEO visits VW plant as defence companies look to expand